Open Access
Infection Prevention in Practice, volume 5, issue 4, pages 100316
Re-purposed drive-through vaccination set-up for Mpox, New York Metropolitan Area
Marina Keller
1
,
Sudha Chaturvedi
1
,
Rebecca Glassman
1
,
Donald S Chen
1
,
Marc El‐Khoury
1
,
Mary Dundas
1
,
Nicholas Feola
1
,
Varghese Thankachen
1
,
Marie Yezzo
1
,
Keri Tone
1
,
Justin Williams
1
,
Renee Garrick
1
Publication type: Journal Article
Publication date: 2023-12-01
Journal:
Infection Prevention in Practice
scimago Q2
SJR: 0.547
CiteScore: 4.8
Impact factor: 1.8
ISSN: 25900889
Infectious Diseases
Public Health, Environmental and Occupational Health
Abstract
This report details how one large medical center in the Metropolitan New York area re-purposed a drive-through COVID-19 vaccination structure to handle a surge in Mpox cases in July 2022. Methods/Results: Simultaneous to on-going COVID -19 vaccination and testing, Mpox vaccination was rolled out in the same drive through structure. More than 1,820 Jynneos (Smallpox and Monkeypox Vaccine, Live, Non-replicating) vaccine dosages were delivered subcutaneously and then intradermally to 1,123 individuals through the open window of their vehicles, averaging 8-10 patients an hour. Five vaccine recipients suffered Mpox rash; there was no exposure among healthcare providers. Drive-through vaccination is an efficient model to be redeployed for future unexpected vaccine initiatives.
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Profiles